FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cho
- This topic has 0 replies, 1 voice, and was last updated 4 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
https://pubmed.ncbi.nlm.nih.gov/32677452/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.